BioSpace News Archive

Innovent Announces First Patient Dosed in a Pivotal Trial of Parsaclisib in Patients with Indolent Lymphoma in China

Innovent Biologics, Inc. announced that the Company achieved first patient dosing in a pivotal Phase 2 registrational trial of parsaclisib, a novel and selective PI3Kδ inhibitor, in China.

April 27, 2020
·
5 min read
Business

Harvard and Astellas Establish Strategic Research Alliance

Collaboration supports advancement of Harvard biomedical research and Astellas drug discovery research in a range of therapeutic areas

April 27, 2020
·
4 min read
Pharm Country

Global Pandemic Consortium supports Trump’s call for investigation of ultraviolet light as a potential treatment for COVID 19

The author, Thomas Fagan is a retired executive of the Medical Technology Industry and founder of Global Pandemic Consortium which he organized to bring individuals, industry, academia and government together to work towards an effective COVID-19 therapy.

April 27, 2020
·
5 min read
BioMidwest

Sovateltide significantly (p=0.0157) improved clinical outcome (modified Rankin Scale) in patients with acute cerebral ischemic stroke when compared to standard of care

Pharmazz, Inc. announced that sovateltide, an endothelin-B receptor agonist, significantly improved modified Rankin Scale of acute cerebral ischemic stroke patients when compared to patients receiving the best standard of care.

April 27, 2020
·
3 min read
Extendicare Provides Business Update Related to COVID-19

Extendicare Inc. provided the following statement related to the ongoing COVID-19 pandemic..

April 27, 2020
·
8 min read
Business

Cipher Pharmaceuticals Schedules Q1 2020 Earnings Release and Conference Call

Cipher Pharmaceuticals Inc. announced it will release its Q1 2020 financial results on Thursday, May 7, 2020. The company will hold a conference call on Friday, May 8, 2020 to discuss the results.

April 27, 2020
·
1 min read